ABCG2 and cancer: ABC transporters have been linked to various human diseases and are considered potential targets for small‐molecule drugs (Moore et al., 2023), particularly in cancer (Muriithi et al., 2020), where they are believed to play a crucial role in the development of drug resistance (Duvivier et al., 2024; Xiao et al., 2021).